Medpace Holdings, Inc.MEDPNASDAQ
Loading
EBITDA Margin Over TimeStable
Percentile Rank50
3Y CAGR+1.9%
5Y CAGR+1.6%
Studio
Year-over-Year Change

EBITDA as a percentage of revenue

3Y CAGR
+1.9%/yr
vs +1.0%/yr prior
5Y CAGR
+1.6%/yr
Consistent
Acceleration
+0.9pp
Accelerating
Percentile
P50
Within normal range
vs 5Y Ago
1.1x
Modest growth
Streak
1 yr
Consecutive declineStable
PeriodValueYoY Change
TTM21.81%-3.4%
202422.58%+17.2%
202319.26%-6.6%
202220.62%+7.2%
202119.23%-4.5%
202020.15%+15.3%
201917.47%-12.0%
201819.85%-22.0%
201725.44%+7.9%
201623.59%-